- Home
- EOG vs GSK Comparison
EOG vs GSK Comparison
Compare EOG & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOG
- GSK
- Stock Information
- Founded
- EOG 1985
- GSK 1715
- Country
- EOG United States
- GSK United Kingdom
- Employees
- EOG N/A
- GSK 70200
- Industry
- EOG Oil & Gas Production
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- EOG Energy
- GSK Health Care
- Exchange
- EOG Nasdaq
- GSK Nasdaq
- Market Cap
- EOG 76.2B
- GSK 68.6B
- IPO Year
- EOG N/A
- GSK N/A
- Fundamental
- Price
- EOG $119.04
- GSK $33.60
- Analyst Decision
- EOG Buy
- GSK Hold
- Analyst Count
- EOG 21
- GSK 5
- Target Price
- EOG $144.32
- GSK $45.50
- AVG Volume (30 Days)
- EOG 3.4M
- GSK 4.3M
- Earning Date
- EOG 02-20-2025
- GSK 02-05-2025
- Dividend Yield
- EOG 3.28%
- GSK 4.63%
- EPS Growth
- EOG N/A
- GSK N/A
- EPS
- EOG 12.40
- GSK 0.81
- Revenue
- EOG $23,864,000,000.00
- GSK $41,966,224,352.00
- Revenue This Year
- EOG $2.97
- GSK $6.50
- Revenue Next Year
- EOG N/A
- GSK $4.54
- P/E Ratio
- EOG $9.60
- GSK $20.12
- Revenue Growth
- EOG 0.58
- GSK 5.59
- 52 Week Low
- EOG $108.94
- GSK $32.83
- 52 Week High
- EOG $139.67
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- EOG 28.39
- GSK 40.58
- Support Level
- EOG $126.00
- GSK $33.58
- Resistance Level
- EOG $134.67
- GSK $34.56
- Average True Range (ATR)
- EOG 2.67
- GSK 0.54
- MACD
- EOG -1.34
- GSK 0.01
- Stochastic Oscillator
- EOG 10.08
- GSK 17.28
About EOG EOG Resources Inc.
EOG Resources is an oil and gas producer with acreage in several US shale plays, primarily in the Permian Basin and the Eagle Ford. At the end of 2023, it reported net proven reserves of 4.5 billion barrels of oil equivalent. Net production averaged roughly 985,000 barrels of oil equivalent per day in 2023 at a ratio of 71% oil and natural gas liquids and 29% natural gas.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.